Functional p75 interleukin-2 receptor expression on the fresh blast cells in childhood acute lymphoblastic leukemia

M Ichikawa1, H Kawai, A Komiyama

  • 1Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.

Insights

Childhood acute lymphoblastic leukemia (ALL) cells with natural killer (NK) properties express functional p75 interleukin-2 receptors (IL-2R). These receptors enhance NK activity and thymidine uptake in leukemia blast cells.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Investigating the immunophenotype and functional characteristics of neoplastic cells in childhood acute lymphoblastic leukemia (ALL).
  • Focusing on leukemic cells exhibiting natural killer (NK) cell properties.

Observation:

  • Neoplastic cells from a pediatric ALL patient displayed NK cell markers (CD56+, CD2+, E-rosette+, CD3-, CD19-) and spontaneous cytotoxicity against K562 target cells.
  • p75 interleukin-2 receptors (IL-2R) were detected on 70% of ALL blast cells using flow cytometry, while p55 Tac antigen was not detectable.
  • Two-color flow cytometry confirmed co-expression of p75 IL-2R and NKH-1 on the blast cells.

Findings:

  • Treatment with recombinant IL-2 (rIL-2) significantly augmented the NK activity of ALL blast cells, increasing cytotoxicity from 22.0% to 38.7%.
  • Despite limited proliferative capacity, rIL-2 treatment induced a 2.7-fold increase in thymidine uptake by the blast cells.
  • These findings demonstrate the presence and functionality of p75 IL-2R on ALL blast cells with NK properties.

Implications:

  • The expression of functional p75 IL-2R suggests potential therapeutic targets for ALL with NK-like features.
  • Understanding IL-2 receptor function in these specific leukemia cells could inform novel treatment strategies.
  • This research contributes to the characterization of unique leukemia cell subsets and their interactions with the immune system.

Related Concept Videos